Steatohepatitis: Causes, Symptoms, Diagnosis, and Treatment
Steatohepatitis is a type of liver inflammation that develops when fat accumulates inside the liver and triggers irritation, swelling, and damage to liver cells. As fat builds up in the liver, it leads to fatty infiltration, which causes inflammation and can progress to more severe liver conditions. Fatty infiltration is a key feature distinguishing steatohepatitis from simple fatty liver, as it is associated with cellular disruption and increased risk of liver damage.
There are two main types:
-
NASH (nonalcoholic steatohepatitis): caused by metabolic factors like obesity, insulin resistance, and high triglycerides
-
ASH (alcoholic steatohepatitis): caused by excessive alcohol use
Understanding steatohepatitis is important because early treatment can prevent long-term liver damage. It is often a ‘silent disease’ with few or no symptoms in its early stages.
Introduction to Liver Disease
Liver disease refers to a wide spectrum of conditions that impact the liver’s ability to function properly. Some of the most common forms include nonalcoholic fatty liver disease (NAFLD), metabolic dysfunction associated steatohepatitis (MASH), and liver cancer. The liver is essential for filtering toxins, processing nutrients, and supporting overall metabolic health. When the liver is affected by disease, it can lead to serious health problems and even life-threatening complications.
Several risk factors increase the likelihood of developing liver disease, such as excess weight, high blood pressure, high cholesterol, and metabolic syndrome. These conditions can contribute to fatty liver disease and metabolic dysfunction associated steatohepatitis, both of which can progress to more severe liver damage if not addressed. Early detection is crucial, and a healthcare team—including a liver specialist—can use a combination of blood tests, imaging studies, and liver biopsy to diagnose and monitor liver disease. Understanding the causes and symptoms of liver disease empowers individuals to seek timely care and make informed decisions about their health.
For Steatohepatitis diagnosis and tracking treatment response, understanding how at-home liver tests work is key to monitoring liver inflammation.
What Is Steatohepatitis (Fatty Liver Disease)?
Steatohepatitis refers to a combination of:
-
Steatosis (fat buildup)
-
Hepatitis (inflammation)
-
Ballooning (swelling of liver cells)
-
Lobular inflammation (inflammatory cell infiltration in the liver lobules)
Steatohepatitis is characterized by hepatocyte injury and cell injury, which can be observed in liver tissue samples.
This inflammation can progress to:
-
Fibrosis
-
Cirrhosis
-
Liver cancer
-
Without treatment, metabolic dysfunction-associated steatohepatitis (MASH) can lead to cirrhosis and liver cancer
Ongoing inflammation and cell injury can lead to liver fibrosis and the formation of scar tissue.
Steatohepatitis is now one of the most common causes of chronic liver disease worldwide.
Types of Steatohepatitis
1. Nonalcoholic Steatohepatitis (NASH)
Non alcoholic steatohepatitis (NASH) occurs in people who drink little or no alcohol and represents a progression from hepatic steatosis, which is the accumulation of fat in the liver. NASH is strongly linked to metabolic health.
Risk factors include:
-
Obesity
-
Type 2 diabetes (a significant risk factor for developing metabolic dysfunction-associated steatohepatitis, or MASH)
-
Prediabetes
-
High cholesterol or triglycerides
-
Metabolic syndrome
-
PCOS
-
Sedentary lifestyle
-
Insulin resistance, which increases the risk of developing MASH
Body mass index is commonly used to assess obesity-related risk factors in NASH. Free fatty acids and other fatty acids, originating from adipose tissue lipolysis and de novo lipogenesis, contribute to liver injury in NASH through mechanisms such as mitochondrial dysfunction and lipid peroxidation, leading to hepatocyte injury and inflammation. Imbalances in gut flora may also play a role in the development of NASH by influencing liver inflammation. Non invasive tests, including blood tests and imaging, are used to assess hepatic steatosis and fibrosis in NASH without the need for liver biopsy. Ongoing inflammation in NASH can result in chronic hepatitis. Typical clinical features of NASH include asymptomatic presentation or nonspecific symptoms, with laboratory findings such as elevated liver enzymes and histological evidence of steatosis, ballooning, and fibrosis. A percentage of patients with NASH are at risk of developing cirrhosis and cardiovascular disease.
NASH may develop silently for years.
2. Alcoholic Steatohepatitis (ASH)
ASH results from heavy or long-term alcohol use.
Risk increases with:
-
Binge drinking
-
Chronic alcohol intake
-
Malnutrition
-
Genetics
Chronic alcohol use can cause liver injury, which triggers activation of stellate cells. Activated stellate cells play a central role in the development of hepatic fibrosis, increasing the risk of progression to cirrhosis.
ASH can rapidly progress to cirrhosis if alcohol use continues.
Symptoms of Steatohepatitis
Many people have no symptoms early on. When symptoms occur, they may include:
-
Fatigue
-
Upper right abdominal discomfort
-
Loss of appetite
-
Unexplained weight changes
-
Weakness
More advanced disease may cause:
-
Jaundice
-
Swelling in legs or abdomen
-
Easy bruising
-
Confusion
These advanced symptoms may result from severe scarring of the liver, which is a sign of significant liver damage. These symptoms indicate liver dysfunction and require urgent care.
Since Steatohepatitis can lead to kidney issues, track the hepatorenal axis using at-home kidney function tests for regular checks.
Causes and Risk Factors
Steatohepatitis has different triggers depending on the type. Morbid obesity is a significant risk factor for developing steatohepatitis.
Causes of NASH
-
Insulin resistance
-
Obesity, especially abdominal fat
-
High-sugar, high-carb diet
-
High triglycerides
-
Genetic predisposition
Causes of ASH
-
Alcohol consumption
-
Nutrient deficiencies
-
Repeated episodes of binge drinking
-
Genetics affecting alcohol metabolism
Given the strong metabolic cause of Steatohepatitis, it's crucial to understand what glucose in urine means, as high sugar drives the condition.
How Steatohepatitis Is Diagnosed
Diagnosing MASH usually involves a combination of physical exam, blood tests, imaging, and sometimes liver biopsy.
A physical exam can reveal signs such as liver enlargement (hepatomegaly) or stigmata of chronic liver disease, which support the diagnosis.
Imaging modalities, including computed tomography (CT), are used to assess liver fat accumulation and fibrosis, alongside other techniques like ultrasound and MRI.
In some cases, a liver biopsy is performed, where examination of liver tissue allows for assessment of inflammation, fibrosis, and other histological features.
1. Blood Tests
These may show:
-
Elevated AST and ALT
-
High GGT
-
Increased inflammation markers
-
Abnormal lipid profile
2. Imaging
-
Ultrasound
-
CT scan
-
MRI with elastography
Imaging shows fat buildup and may estimate fibrosis.
3. Liver Biopsy
A biopsy is the gold standard for distinguishing simple steatosis from steatohepatitis. It shows inflammation, ballooning, and scarring. The FDA has approved the use of resmetirom for people with steatohepatitis and stage 2 or 3 fibrosis, alongside diet and exercise.
Complications of Steatohepatitis
If untreated, steatohepatitis may progress to:
-
Fibrosis
-
Cirrhosis (a condition called cirrhosis, which results from extensive scar tissue)
-
Liver failure
-
Hepatocellular carcinoma (liver cancer)
-
Liver transplantation as a last resort for patients with decompensated cirrhosis due to steatohepatitis
Chronic inflammation and fibrosis can increase the risk of developing liver cancer over time.
NASH is now one of the leading causes of liver transplant.
Monitor hydration and protein loss (a sign of kidney damage) with a comprehensive urine test to manage systemic complications.
Treatment for Steatohepatitis
Treating liver disease requires a comprehensive approach involving the health care team. Treatment depends on whether the cause is metabolic or alcohol-related.
1. Lifestyle Changes (First-Line Treatment for NASH)
-
Weight loss (7 to 10 percent improves liver inflammation, while greater than 10 percent may improve fibrosis of the liver, and even 3-5% weight loss may improve steatosis within the liver)
-
Regular physical activity
-
Low-sugar, low-refined-carb diet
-
Reducing saturated fats
-
Increasing high-fiber foods
Even modest changes can significantly reduce inflammation.
2. Managing Underlying Conditions
-
Controlling blood sugar
-
Treating insulin resistance
-
Lowering cholesterol and triglycerides
-
Managing high blood pressure
Medications like SGLT2 inhibitors and GLP-1 receptor agonists may help. Antioxidants such as vitamin E are of modest benefit in treating steatohepatitis. Statins should not be withheld in patients with steatohepatitis due to pre-existing abnormal liver biochemical tests.
3. Alcohol Cessation (Essential for ASH)
-
Complete alcohol abstinence is necessary
-
Support programs may help maintain sobriety
4. Medications Under Research
Several medications for NASH are being evaluated, including:
-
Anti-inflammatory agents
-
Fibrosis-targeting drugs
-
Metabolic regulators
No single medication is yet approved specifically for NASH, but treatment is evolving.
5. Vitamin E (Selective Cases)
Some evidence suggests Vitamin E may help non-diabetic NASH patients, under medical supervision.
6. Weight-Loss Surgery
Bariatric surgery may be considered for severe obesity and can significantly improve NASH.
Preventing Liver Disease
Taking steps to prevent liver disease is vital for long-term health. The most effective prevention strategies focus on maintaining a healthy lifestyle. This includes following a balanced, healthy diet rich in fruits, vegetables, and whole grains, while limiting unhealthy fats and processed foods. Regular physical activity and achieving or maintaining a healthy weight are also key factors in reducing the risk of liver disease.
People with risk factors such as obesity, diabetes, or high blood pressure should be especially proactive. Losing weight, if needed, and managing underlying health conditions can significantly lower the risk of developing liver disease. It’s also important to avoid excessive alcohol consumption and to have regular check-ups with a healthcare provider, who can monitor liver health through routine blood tests and other assessments. Early detection and intervention can make a significant difference in preventing the progression of liver disease and improving overall outcomes.
Can Steatohepatitis Be Reversed?
In many cases, yes — especially in early stages.
NASH and ASH can improve with:
-
Weight loss
-
Diet changes
-
Exercise
-
Alcohol cessation
-
Better metabolic control
Fibrosis may stabilize or partially reverse with consistent care.
However, cirrhosis is usually permanent.
Living with Steatohepatitis
Managing steatohepatitis, also known as nonalcoholic steatohepatitis (NASH), involves a combination of lifestyle changes and medical care. This condition is marked by inflammation and fat buildup in the liver, which can lead to liver damage, scarring, and increase the risk of liver cirrhosis and liver cancer if left untreated. Working closely with a healthcare team is essential to develop a personalized treatment plan.
Key strategies for living with steatohepatitis include losing weight through a healthy diet and regular exercise, which can help reduce fat buildup and improve liver health. Managing high cholesterol, diabetes, and other metabolic conditions with the help of your healthcare provider is also important. In some cases, medications may be prescribed, and for those with severe obesity, bariatric surgery may be considered to support weight loss and metabolic improvement. Regular follow-up appointments and monitoring are crucial to track progress and prevent complications. With the right support and commitment to lifestyle changes, individuals with steatohepatitis can take control of their health and reduce the risk of serious liver-related outcomes.
When to See a Doctor
Seek medical evaluation if you experience:
-
Persistent fatigue
-
Unexplained abdominal discomfort
-
Elevated liver enzymes
-
Family history of liver disease
-
Metabolic risk factors such as diabetes or obesity
Urgent care is needed for jaundice, confusion, swelling, or vomiting blood.
Chronic liver inflammation increases infection risk. Manage this potential complication with our guide on urinary tract infections (UTIs).
The Bottom Line
Steatohepatitis is a more serious form of fatty liver disease where inflammation and fat buildup damage liver cells. Whether caused by alcohol or metabolic factors, early diagnosis and lifestyle changes can prevent long-term liver damage.
By addressing diet, metabolic health, alcohol use, and other risk factors, many people can slow or even reverse the progression of steatohepatitis.
Want to check your liver inflammation or fatty liver status from home?
You can take an at-home liver enzyme and metabolic panel test through Ribbon Checkup and get results instantly.
Explore liver and metabolic tests
Related resources
References
Cleveland Clinic. (n.d.). Steatotic (fatty) liver disease. Retrieved December 3, 2025, from https://my.clevelandclinic.org/health/diseases/15831-fatty-liver-disease
Clinical review. (2021). Non-alcoholic steatohepatitis: Pathogenesis, diagnosis, and clinical implications. Frontiers in Cardiovascular Medicine, 8, 742382. https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.742382/full
Epidemiology study. (2023). The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology, 77(4), 1043–1059. https://journals.lww.com/hep/fulltext/2023/04000/the_global_epidemiology_of_nonalcoholic_fat.27.aspx
Guideline / Consensus. (2021). Evidence-based clinical practice guidelines for NAFLD/NASH. Journal of Gastroenterology, 56(11), 1051–1078. https://link.springer.com/article/10.1007/s00535-021-01796-x
Mayo Clinic. (2024, February 16). Nonalcoholic fatty liver disease: Symptoms & causes. https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567
Review. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. Biomolecules, 12(3), 452. https://pubmed.ncbi.nlm.nih.gov/35287643/
Review. (2024). A comprehensive updated review of risk factors, symptoms, and treatment of non-alcoholic steatohepatitis. Heliyon, 10(23), e31682. https://www.sciencedirect.com/science/article/pii/S2405844024044992
Review. (2012). Nonalcoholic fatty liver disease: Definitions, risk factors, and NAFLD vs NASH distinction. Clinical Liver Disease, 1(2), 52–56. https://onlinelibrary.wiley.com/doi/full/10.1002/cld.81
StatPearls / NIH Bookshelf. (2024). Nonalcoholic steatohepatitis (NASH). In StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK470243/
